This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Corticosteroids (in rheumatoid arthritis)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Steroid treatment is widely used in rheumatoid arthritis. It is used as an adjunct to anti-inflammatory drugs and disease modifying anti-rheumatic drugs (DMARDs). It usually helps improve symptoms rapidly during an acute flare or whilst a DMARD has time to take effect (a 'bridging treatment'). In the elderly it is often also used in low dose to help maintain remission.

  • steroids may be administered orally, intra-muscularly and intra-articularly.
  • for 'bridging treatment' (specialist advice required), intra-articular corticosteroids may be considered for localised disease, and systemic corticosteroids for more generalised disease
    • for a monoarticular flare, if appropriate, an intra-articular corticosteroid injection will often give rapid relief of symptoms - intra-articular corticosteroid injections should always be administered by an appropriately skilled person
    • systemic corticosteroids can be considered for a monoarticular flare if intra-articular injection is not possible, or for a polyarticular flare
  • concern however continues about the potential side-effects of corticosteroid use, including Cushing's syndrome, osteoporosis, hypertension etc.
    • with respect to risk of osteoporosis
      • in patients either committed to long-term oral corticosteroids or who have been exposed to long-term oral corticosteroid treatment for three months or more, osteoporosis prophylaxis is recommended if patients are aged 65 years or over, or aged under 65 years with a history of a previous fragility fracture. In the absence of a prior fragility fracture in those aged under 65 years, a bone mineral density (BMD) test is recommended and osteoporosis prophylaxis should be considered where the T-score is -1.5 standard deviation (SD) or lower
      • increased osteoporosis risk is seen even at daily doses of prednisolone less than 7.5mg
      • note also that RA increases the risk of osteoporosis even in the absence of corticosteroid therapy

NICE suggest that:

  • offer short-term treatment with glucocorticoids for managing flares in adults with recent-onset or established disease to rapidly decrease inflammation
  • in adults with established RA, only continue long-term treatment with glucocorticoids when:
    • the long-term complications of glucocorticoid therapy have been fully discussed, and
    • all other treatment options (including biological and targeted synthetic DMARDs) have been offered


  1. MeReC Bulletin 2007;17(5):1-8
  2. NICE (July 2018). Rheumatoid arthritis- The management of rheumatoid arthritis in adults

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.